Cellebrite insider plans tax-driven share sale
Cellebrite DI Ltd. (CLBT) is the issuer for which Thomas E. Hogan has filed a Rule 144 notice covering ordinary shares, par value NIS 0.00001 per share, listed on Nasdaq.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cellebrite DI Ltd. (CLBT) is the issuer for which Thomas E. Hogan has filed a Rule 144 notice covering ordinary shares, par value NIS 0.00001 per share, listed on Nasdaq. The shares relate to restricted share units vested under an issuer S-8 registered compensation plan.
The reporting person states an intention to sell shares on 08/25/2026 through Morgan Stanley Smith Barney LLC under a mandatory, non-discretionary sell-to-cover arrangement solely to satisfy income tax liabilities from RSU vesting. Recent activity includes open-market sales of Cellebrite ordinary shares during the past three months.
Key Figures
Key Terms
Rule 144 regulatory
S-8 Registered Plan regulatory
sell-to-cover arrangement financial
income tax liabilities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for CLBT by Thomas E. Hogan disclose?
What type of CLBT security is covered by this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.